AI assistant
Sending…
Predictive Oncology Inc. — Director's Dealing 2012
Aug 15, 2012
35106_dirs_2012-08-15_2a7c7125-7a2f-42e8-9f1c-e7cb5e808883.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioDrain Medical, Inc. (BIOR)
CIK: 0001446159
Period of Report: 2012-08-13
Reporting Person: Kornberg Joshua (Director, CEO and President, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-13 | Non-qualified Stock Options | $0.08 | A | 6000000 | Acquired | 2022-08-13 | Common Stock, par value $0.01 per share (6000000) | Direct |
Footnotes
F1: The grant of non-qualified stock options to Mr. Kornberg was made pursuant to his Employment Agreement, dated as of August 13, 2012, with BioDrain Medical, Inc. and was made in consideration of his entering into such Employment Agreement.
More from Predictive Oncology Inc.
Capital/Financing Update
2026
Jun 9
Regulatory Filings
2026
Jun 9
Earnings Release
2026
May 15
Capital/Financing Update
2026
May 15
Capital/Financing Update
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 16
Board/Management Information
2026
Apr 1